Carlos Anderson
Nurse Practitioner · Sevierville, TNNPI 1578055836
Payments from drug & device makers
Across 278 payments — averaging $19.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$718
- Dexcom, Inc.$638
- Xeris Pharmaceuticals, Inc.$500
- Novo Nordisk$489
- Abbott$406
- Amgen$339
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,398100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 44 | $718 |
| Dexcom, Inc. | 25 | $638 |
| Xeris Pharmaceuticals, Inc. | 28 | $500 |
| Novo Nordisk | 28 | $489 |
| Abbott | 19 | $406 |
| Amgen | 21 | $339 |
| Insulet Corporation | 15 | $280 |
| Medtronic | 15 | $267 |
| Mannkind Corporation | 10 | $196 |
| Corcept Therapeutics | 10 | $186 |
| Radius Health, Inc. | 8 | $186 |
| Bayer | 9 | $153 |
| Cequr Corporation | 2 | $126 |
| BETA Bionics, Inc. | 4 | $117 |
| Sanofi-aventis U.S. LLC | 6 | $113 |
| Sequel Med Tech, LLC | 4 | $99 |
| Tandem Diabetes Care, Inc. | 4 | $98 |
| Boehringer Ingelheim | 5 | $90 |
| Ascendis Pharma Endocrinology Inc | 4 | $73 |
| Amphastar Pharmaceuticals, Inc. | 4 | $65 |
| AbbVie | 3 | $47 |
| AstraZeneca | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $40 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Chiesi USA, Inc. | 1 | $21 |
| Rhythm Pharmaceuticals, Inc. | 1 | $20 |
| IBSA Pharma Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$111
How this compares
$5,398 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $112,032 |
| MounjaroTirzepatide | 77 | $100,295 |
| JardianceEmpagliflozin | 80 | $97,294 |
| Tresiba Flextouch U-100Insulin Degludec | 20 | $19,970 |
| Fiasp FlextouchInsulin Aspart (Niacinamide) | 14 | $18,926 |
| TrulicityDulaglutide | 12 | $18,394 |
| JanuviaSitagliptin Phosphate | 17 | $16,106 |
| Tresiba Flextouch U-200Insulin Degludec | 13 | $14,198 |
| FarxigaDapagliflozin Propanediol | 15 | $12,790 |
| Novolog FlexpenInsulin Aspart | 29 | $12,327 |
| Humulin R U-500 KwikpenInsulin Regular, Human | 14 | $11,778 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 63 | $11,460 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 20 | $1,972 |
| Metformin Hcl ErMetformin Hcl | 100 | $711 |
| Levothyroxine Sodium | 71 | $652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $718 | $118,68989 claims |
| Novo NordiskOzempic | $489 | $112,03269 claims |
| Boehringer IngelheimJardiance | $90 | $97,29480 claims |
| AstraZenecaFarxiga | $44 | $12,79015 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $38 | $65271 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Other nurse practitioner in Sevierville
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
- Cara StoutKingsport$71K
- S Marie HamiltonOoltewah$64K
- Cynthia WilsonChattanooga$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.